BMI Clinical Trials

21 recruitingLast updated: May 29, 2026

There are 21 actively recruiting bmi clinical trials across 12 countries. Studies span Not Applicable, Phase 2, Early Phase 1, Phase 3. Top locations include Bondy, France, Columbia, South Carolina, United States, Girona, Girona, Spain. Updated daily from ClinicalTrials.gov.


BMI Trials at a Glance

21 actively recruiting trials for bmi are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 12 trials, with the heaviest enrollment activity in Bondy, Columbia, and Girona. Lead sponsors running bmi studies include Aphaia Pharma US LLC, Assistance Publique - Hôpitaux de Paris, and AB Biotics, SA.

Browse bmi trials by phase

Treatments under study

About BMI Clinical Trials

Looking for clinical trials for BMI? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new BMI trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about BMI clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 21 trials

Recruiting
Phase 2

Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial

MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseFatty Liver Disease, NonalcoholicOverweight (BMI > 25)
AB Biotics, SA60 enrolled1 locationNCT07193927
Recruiting
Not Applicable

Stable Isotopes- Adults With Obesity

Protein metabolismGlucose metabolismObese Patients (BMI ≥ 30 kg/m²)
University of Illinois at Urbana-Champaign8 enrolled1 locationNCT07020741
Recruiting
Not Applicable

Sustainable and Inclusive Use of Alternative Proteins in Mediterranean Supply Chains (CIPROMED)

Gut MicrobiotaOverweight (BMI > 25)Food Preferences+2 more
University of Bologna40 enrolled1 locationNCT07553936
Recruiting
Not Applicable

Effects of Body Composition on Vascular Health in Females With a Healthy Body Weight

BMIStressNormal-weight Obesity
Ball State University30 enrolled1 locationNCT06818500
Recruiting
Not Applicable

Probiotic Impact on Cognitive Performance, and Metabolic Outcomes in Overweight Young Adults With Impaired Glucose Regulation

Cognitive DysfunctionPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)Overweight (BMI > 25)+3 more
Leeds Beckett University70 enrolled1 locationNCT07073781
Recruiting
Not Applicable

Anti-Inflammatory Effects of Pecan Nut Oil Supplementation in Adults With Overweight: A Randomized Controlled Parallel-Group Clinical Trial

Overweight (BMI > 25)
Universidad Autonoma de Nuevo Leon50 enrolled1 locationNCT07497555
Recruiting
Not Applicable

Time Restricted-EAting for Type 2 Diabetes and MEtabolic Health: the TEA TIME Trial

Type 2 DiabetesOverweight (BMI > 25)
Mount Sinai Hospital, Canada112 enrolled1 locationNCT07272460
Recruiting
Not Applicable

Pistachio Snacking and Metabolic Flexibility

Overweight or obeseHealthy ParticipantsObese Patients (BMI ≥ 30 kg/m²)+4 more
University of South Carolina60 enrolled1 locationNCT07340125
Recruiting
Not Applicable

Redox Status and Exercise Training-induced Adaptations

ObesityOverweight (BMI > 25)
University of Thessaly60 enrolled1 locationNCT07196852
Recruiting
Not Applicable

Follow up Study of Varapodio Trial: Effect of Longevity and Fasting Mimicking Diet on Risk Factors Age Correlated and Biomarkers of Aging

fat massObesity (Disorder)Risk Behavior+4 more
Fondazione Valter Longo135 enrolled1 locationNCT07255300
Recruiting

Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.

Obesity, OverweightOverweight (BMI > 25)
Medialis Ltd.500 enrolled1 locationNCT07229027
Recruiting
Phase 2

Effect of Ketone Esters on Liver Fat Content and Metabolic Function

ObesityOverweight (BMI > 25)MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Washington University School of Medicine40 enrolled1 locationNCT07097506
Recruiting
Not Applicable

Eatit's Obesity Intervention: Effects on Weight, Eating Habits and Health

Obese Patients (BMI ≥ 30 kg/m²)Overweight and Obese Adults
Eatit AB93 enrolled1 locationNCT07183228
Recruiting
Phase 2

A Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations Combined With a Gel Composition Compared to Placebos in Obese Subjects With Weight Related Comorbidities

Obese Patients (BMI ≥ 30 kg/m²)Obese With Comorbidities
Aphaia Pharma US LLC102 enrolled6 locationsNCT07008456
Recruiting
Not Applicable

Therapeutic Potential of a Synbiotic to Improve Mental Health in Subjects With Obesity.

Depressive DisorderAnxietyObese Patients (BMI ≥ 30 kg/m²)
Celia Bañuls120 enrolled1 locationNCT06901739
Recruiting
Early Phase 1

L. Acidophilus (Strain TW01) on Gut Health, Body Composition, and Inflammation

Overweight (BMI > 25)Obese, Otherwise Healthy Volunteers
University of Connecticut12 enrolled1 locationNCT06912100
Recruiting
Not Applicable

Interest of Hypnosis When Setting up Non-invasive Ventilation in a Conscious Patient With COPD and/or Obesity With a BMI Greater Than 30, Suffering Fromacute Respiratory Distress in Adult Intensive Care

Chronic Obstructive Pulmonary Disease (COPD)Obesity With a BMI Greater Than 30Acute Respiratory Distress in Adult Intensive Care
Rennes University Hospital50 enrolled1 locationNCT04220463
Recruiting

Correlation of Preoperative Gastric Residual Volume With Body Mass Index and Aspiration Risk in Laparoscopic Bariatric Surgery

Body mass index (BMI)ObesityGastric Ultrasound+1 more
Fatih Sultan Mehmet Training and Research Hospital60 enrolled1 locationNCT07032207
Recruiting

GCS Survey: "GHB IN CHEMICAL SUBMISSION: MYTH OR REALITY?"

CHEMICAL SUBMISSION
Assistance Publique - Hôpitaux de Paris200 enrolled3 locationsNCT06137599
Recruiting
Phase 3

Can a pre-conception weight loss program improve maternal and infant outcomes for women with overweight or obesity? A pragmatic randomised controlled trial (RCT).

Women with obesity BMI greater than 30kg/m2Women with overweight (BMI greater than 25kg/m2 to less than 30kg/m2 )
The University of Sydney1,927 enrolled6 locationsACTRN12620001238965